Caribou Biosciences develops cell therapies for blood cancers using gene editing. It last closed at $0.28 on Nov 20, down 8.44% on the day. The next earnings report for CRBU is expected around Thu, Mar 4, 2027, after the close. For the quarter ended Sep 2026, CRBU reported EPS of -$0.25 on revenue of $1.6M, with revenue down 26.9% from a year ago. Over its last 8 reports the stock moved an average of 5.5% the session after earnings. Over the last 12 months CRBU insiders bought $0 of stock on the open market and sold $47K, according to SEC Form 4 filings.
AI Auto Pilots
Is CRBU in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CRBU.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CRBUStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CRBU · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 42% below its 20 day and 153% below its 50 day average. It is 444% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 21), oversold. The nearest support is the 52 week low at $0.28, and the nearest resistance the Pivot at $0.29.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 15.3%/day
Key levels
$2.4952 week high+789.3%
$1.55200 day average+453.6%
$1.18100 day average+321.4%
$0.7250 day average+157.1%
$0.47Swing high (Nov 4)+67.9%
$0.4020 day average+42.9%
$0.30Pivot R1+7.1%
$0.29Pivot+3.6%
$0.2852 week low+0.0%
$0.28Pivot S1+0.0%
$0.28Last close
Indicators
RSI (14)
20.61
Oversold below 30
Oversold
MACD
-0.11
Above its signal line
Bullish
Stochastic
5.3
Near the bottom of its range
Oversold
ADX (14)
59.4
Strong downtrend
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-157.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−36.6%
Change over 10 sessions
Bearish
ATR (14)
$0.04
Typical daily range, 15.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 72.6%/day
Key levels
$2.4952 week high+789.3%
$1.55200 day average+453.6%
$1.18100 day average+321.4%
$0.7250 day average+157.1%
$0.47Swing high (Nov 4)+67.9%
$0.4020 day average+42.9%
$0.30Pivot R1+7.1%
$0.29Pivot+3.6%
$0.2852 week low+0.0%
$0.28Pivot S1+0.0%
$0.28Last close
Indicators
RSI (14)
24.54
Oversold below 30
Oversold
MACD
-0.38
Below its signal line
Bearish
Stochastic
1.3
Near the bottom of its range
Oversold
ADX (14)
28.8
Trending down
Williams %R
-99.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-117.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−77.6%
Change over 10 sessions
Bearish
ATR (14)
$0.21
Typical daily range, 72.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CRBU
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CRBU did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CRBU usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CRBUHow many large options trades hit CRBU, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CRBU in the last 90 days.
From SEC Form 4 filings by CRBU's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CRBU is in one of them and how their past CRBU trades turned out.
Caribou Biosciences is a biopharmaceutical company based in Berkeley, California. It develops cell therapies for cancers of the blood, using a gene editing method built on CRISPR technology. Its lead product candidates are CAR-T cell therapies made from healthy donor cells, and they are in clinical trials for patients with lymphoma or multiple myeloma that has returned or did not respond to earlier treatment.